Login
 Forum
 
 
Personal data sheet
 Print preview
personal data approved: 2018. II. 05.
Personal data
Anna Sebestyén
name Anna Sebestyén
name of institution
doctoral school
SE Doctoral School of Clinical Medicine (Supervisor)
SE Doctoral School of Pathological Sciences (Supervisor)
the share of work in the different doctoral schools. SE Doctoral School of Clinical Medicine 50%
SE Doctoral School of Pathological Sciences 50%
accreditation statement submitted to: Semmelweis University, Budapest
Contact details
E-mail address annakorb1.sote.hu
phone number +36 1 459-1500/54447
mobile phone number +36 20 825-0258
Academic title
scientific degree, title Ph.D.
year degree was obtained 1998
discipline to which degree belongs theoretical medicine
institution granting the degree Semmelweis Orvostudományi Egyetem, Doktori Iskola (to be translated)
Employment
1998 - Semmelweis University, Budapest
egyetemi kutató
Thesis topic supervisor
number of doctoral students supervised until now 4
number of students who fulfilled course requirements 4
students who obtained their degrees:
Noémi Nagy PhD 2018  DSPS2-SE
Tamás Béla Sticz PhD 2018  DSPS2-SE
Ágnes Kovácsné Márk PhD 2013  DSPS2-SE
Melinda Hajdu PhD 2009  DSPS2-SE

students with degree granting in process:
Zoltán Hujber PhD (2019/08)  DSPS2-SE
completed course requirement, without degree or degree granting in process:
Gábor Petővári (PhD) 2018/08  DSPS2-SE
present PhD students:
Titanilla Dankó (PhD) (2022/08)  DSPS2-SE
(50%) Luca Felkai (PhD) (2021/08)  DSCM-SE
  Thesis topic proposals
Research
research area The role of mTOR activity in anti-apoptotic and survival signalling network, in therapy resistance of tumor cells
research field in which current research is conducted theoretical medicine
clinical medicine
Publications
2018

Nagy AM, Fekete R, Horvath G, Koncsos G, Kriston C, Sebestyen A, Giricz Z, Kornyei Z, Madarasz E, Tretter L: Versatility of microglial bioenergetic machinery under starving conditions, BIOCHIMICA ET BIOPHYSICA ACTA 1859: (3) pp. 201-214.
type of document: Journal paper/Article
language: English
DOI 
2017

Krencz I, Sebestyen A, Fabian K, Mark A, Moldvay J, Khoor A, Kopper L, Papay J: Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma., HUMAN PATHOLOGY 62: pp. 66-73.
type of document: Journal paper/Article
number of independent citations: 1
language: English
DOI 
2017

Hujber Z, Petovari G, Szoboszlai N, Danko T, Nagy N, Kriston C, Krencz I, Paku S, Ozohanics O, Drahos L, Jeney A, Sebestyen A: Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells, JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH 36: (1) Paper 74. 12 p.
type of document: Journal paper/Article
language: English
URL 
2017

Sticz T, Molnar A, Mark A, Hajdu M, Nagy N, Vegso G, Micsik T, Kopper L, Sebestyen A: mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression., JOURNAL OF CLINICAL PATHOLOGY 70: (5) pp. 410-416.
type of document: Journal paper/Article
number of independent citations: 2
language: English
DOI 
2013

Mark A, Hajdu M, Varadi Z, Sticz TB, Nagy N, Csomor J, Berczi L, Varga V, Csoka M, Kopper L, Sebestyen A: Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease - a combined tissue microarray, in vitro and in vivo study., BMC CANCER 13: Paper 250. 12 p.
type of document: Journal paper/Article
number of independent citations: 15
language: English
DOI 
2013

Nemes K, Sebestyen A, Mark A, Hajdu M, Kenessey I, Sticz T, Nagy E, Barna G, Varadi Z, Kovacs G, Kopper L, Csoka M: Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL)., PLOS ONE 8: (4) Paper e59335. 11 p.
type of document: Journal paper/Article
number of independent citations: 9
language: English
URL 
2012

Sebestyen A, Sticz TB, Mark A, Hajdu M, Timar B, Nemes K, Nagy N, Varadi Z, Kopper L: Activity and complexes of mTOR in diffuse large B-cell lymphomas-a tissue microarray study., MODERN PATHOLOGY 25: (12) pp. 1623-1628.
type of document: Journal paper/Article
number of independent citations: 4
language: English
DOI 
2011

Egervari G, Mark A, Hajdu M, Barna G, Sapi Z, Krenacs T, Kopper L, Sebestyen A: Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein, HISTOCHEMISTRY AND CELL BIOLOGY 135: (4) pp. 409-417.
type of document: Journal paper/Article
number of independent citations: 3
language: English
DOI 
1999

Sebestyen A, Berczi L, Mihalik R, Paku S, Matolcsy A, Kopper L: Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas, BRITISH JOURNAL OF HAEMATOLOGY 104: (2) pp. 412-419.
type of document: Journal paper/Article
number of independent citations: 42
language: English
DOI 
1998

Peták I, Mihalik R, Bauer PI, Süli-Vargha H, Sebestyén A, Kopper L: BCNU is a caspase-mediated inhibitor of drug-induced apoptosis, CANCER RESEARCH 58: (4) pp. 614-618.
type of document: Journal paper/Article
number of independent citations: 23
language: English
Number of independent citations to these publications:99 
Scientometric data
list of publications and citations
number of scientific publications that meet accreditation criteria:
70
number of scientific publications:
97
monographs and professional books:
1
monographs/books in which chapters/sections were contributed:
1 
scientific publications published abroad that meet the accreditation criteria:
51
publications not in Hungarian, published in Hungary, meeting the accreditation criteria:
0
number of independent citations to scientific publications and creative works:
657

 
All rights reserved © 2007, Hungarian Doctoral Council. Doctoral Council registration number at commissioner for data protection: 02003/0001. Program version: 2.2358 ( 2017. X. 31. )